Takeshita N, Enokida T, Okano S, Fujisawa T, et al. Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Oral Oncol 2023;147:106615.
PMID: 37931493